id I10-R141-11086-552953
record_format dspace
institution Universidad Nacional de Córdoba
institution_str I-10
repository_str R-141
collection Repositorio Digital Universitario (UNC)
language Inglés
topic Amphetamine
AT1-R
Dopamine reuptake
Locomotor activity
Schizophrenia
Social interaction
spellingShingle Amphetamine
AT1-R
Dopamine reuptake
Locomotor activity
Schizophrenia
Social interaction
Basmadjian, Osvaldo M.
Occhieppo, Victoria B.
Montemerlo, Antonella E.
Rivas, Gustavo A.
Rubianes, María D.
Baiardi, Gustavo
Bregonzio, Claudia
Angiotensin II involvement in the development and persistence of amphetamine-induced sensitization: Striatal dopamine reuptake implications
topic_facet Amphetamine
AT1-R
Dopamine reuptake
Locomotor activity
Schizophrenia
Social interaction
description Impact Factor: 2023 (2024 update): 2.7
author2 https://orcid.org/0000-0003-2354-6164
author_facet https://orcid.org/0000-0003-2354-6164
Basmadjian, Osvaldo M.
Occhieppo, Victoria B.
Montemerlo, Antonella E.
Rivas, Gustavo A.
Rubianes, María D.
Baiardi, Gustavo
Bregonzio, Claudia
format publishedVersion
article
author Basmadjian, Osvaldo M.
Occhieppo, Victoria B.
Montemerlo, Antonella E.
Rivas, Gustavo A.
Rubianes, María D.
Baiardi, Gustavo
Bregonzio, Claudia
author_sort Basmadjian, Osvaldo M.
title Angiotensin II involvement in the development and persistence of amphetamine-induced sensitization: Striatal dopamine reuptake implications
title_short Angiotensin II involvement in the development and persistence of amphetamine-induced sensitization: Striatal dopamine reuptake implications
title_full Angiotensin II involvement in the development and persistence of amphetamine-induced sensitization: Striatal dopamine reuptake implications
title_fullStr Angiotensin II involvement in the development and persistence of amphetamine-induced sensitization: Striatal dopamine reuptake implications
title_full_unstemmed Angiotensin II involvement in the development and persistence of amphetamine-induced sensitization: Striatal dopamine reuptake implications
title_sort angiotensin ii involvement in the development and persistence of amphetamine-induced sensitization: striatal dopamine reuptake implications
publisher Federation of European Neuroscience Societies
publishDate 2024
url http://hdl.handle.net/11086/552953
https://rdu.unc.edu.ar/handle/11086/18306
https://onlinelibrary.wiley.com/doi/abs/10.1111/ejn.16312
https://pubmed.ncbi.nlm.nih.gov/38480476/
https://doi.org/10.1111/ejn.16312
work_keys_str_mv AT basmadjianosvaldom angiotensiniiinvolvementinthedevelopmentandpersistenceofamphetamineinducedsensitizationstriataldopaminereuptakeimplications
AT occhieppovictoriab angiotensiniiinvolvementinthedevelopmentandpersistenceofamphetamineinducedsensitizationstriataldopaminereuptakeimplications
AT montemerloantonellae angiotensiniiinvolvementinthedevelopmentandpersistenceofamphetamineinducedsensitizationstriataldopaminereuptakeimplications
AT rivasgustavoa angiotensiniiinvolvementinthedevelopmentandpersistenceofamphetamineinducedsensitizationstriataldopaminereuptakeimplications
AT rubianesmariad angiotensiniiinvolvementinthedevelopmentandpersistenceofamphetamineinducedsensitizationstriataldopaminereuptakeimplications
AT baiardigustavo angiotensiniiinvolvementinthedevelopmentandpersistenceofamphetamineinducedsensitizationstriataldopaminereuptakeimplications
AT bregonzioclaudia angiotensiniiinvolvementinthedevelopmentandpersistenceofamphetamineinducedsensitizationstriataldopaminereuptakeimplications
_version_ 1806949389967556608
spelling I10-R141-11086-5529532024-07-30T20:12:52Z Angiotensin II involvement in the development and persistence of amphetamine-induced sensitization: Striatal dopamine reuptake implications Basmadjian, Osvaldo M. Occhieppo, Victoria B. Montemerlo, Antonella E. Rivas, Gustavo A. Rubianes, María D. Baiardi, Gustavo Bregonzio, Claudia https://orcid.org/0000-0003-2354-6164 https://orcid.org/0000-0002-9325-3458 https://orcid.org/0000-0001-5665-2380 https://orcid.org/0000-0001-7411-6821 https://orcid.org/0000-0003-0729-7401 https://orcid.org/0000-0003-3542-2177 Amphetamine AT1-R Dopamine reuptake Locomotor activity Schizophrenia Social interaction Impact Factor: 2023 (2024 update): 2.7 info:eu-repo/semantics/publishedVersion Fil: Basmadjian, Osvaldo M. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacología; Argentina. Fil: Basmadjian, Osvaldo M. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Farmacología Experimental de Córdoba; Argentina. Fil: Occhieppo, Victoria B. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacología; Argentina. Fil: Occhieppo, Victoria B. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Farmacología Experimental de Córdoba; Argentina. Fil: Montemerlo, Antonella E. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Fisicoquímica; Argentina. Fil: Montemerlo, Antonella E. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Físico-Química de Córdoba; Argentina. Fil: Rivas, Gustavo A. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Fisicoquímica; Argentina. Fil: Rivas, Gustavo A. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Físico-Química de Córdoba; Argentina. Fil: Rubianes, María D. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Fisicoquímica; Argentina. Fil: Rubianes, María D. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Físico-Química de Córdoba; Argentina. Fil: Baiardi, Gustavo. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas, Físicas y Naturales. Laboratorio de Neurofarmacología; Argentina. Fil: Baiardi, Gustavo. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones Biológicas y Tecnológicas; Argentina. Fil: Bregonzio, Claudia. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Fisicoquímica; Argentina. Fil: Bregonzio, Claudia. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Farmacología Experimental de Córdoba; Argentina. Amphetamine (AMPH) exposure induces behavioural and neurochemical sensitization observed in rodents as hyperlocomotion and increased dopamine release in response to a subsequent dose. Brain Angiotensin II modulates dopaminergic neurotransmission through its AT1 receptors (AT1-R), positively regulating striatal dopamine synthesis and release. This work aims to evaluate the AT1-R role in the development and maintenance of AMPH-induced sensitization. Also, the AT1-R involvement in striatal dopamine reuptake was analysed. The sensitization protocol consisted of daily AMPH administration for 5 days and tested 21 days after withdrawal. An AT1-R antagonist, candesartan, was administered before or after AMPH exposure to evaluate the participation of AT1-R in the development and maintenance of sensitization, respectively. Sensitization was evaluated by locomotor activity and c-Fos immunostaining. Changes in dopamine reuptake kinetics were evaluated 1 day after AT1-R blockade withdrawal treatment, with or without the addition of AMPH in vitro. The social interaction test was performed as another behavioural output. Repeated AMPH exposure induced behavioural and neurochemical sensitization, which was prevented and reversed by candesartan. The AT1-R blockade increased the dopamine reuptake kinetics. Neither the AMPH administration nor the AT1-R blockade altered the performance of social interaction. Our results highlight the AT1-R's crucial role in AMPH sensitization. The enhancement of dopamine reuptake kinetics induced by the AT1-R blockade might attenuate the neuroadaptive changes that lead to AMPH sensitization and its self-perpetuation. Therefore, AT1-R is a prominent candidate as a target for pharmacological treatment of pathologies related to dopamine imbalance, including drug addiction and schizophrenia. Datos de investigación. Todos los datos en los que se basan los resultados están plenamente disponibles en https://rdu.unc.edu.ar/handle/11086/18306 info:eu-repo/semantics/publishedVersion Fil: Basmadjian, Osvaldo M. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacología; Argentina. Fil: Basmadjian, Osvaldo M. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Farmacología Experimental de Córdoba; Argentina. Fil: Occhieppo, Victoria B. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacología; Argentina. Fil: Occhieppo, Victoria B. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Farmacología Experimental de Córdoba; Argentina. Fil: Montemerlo, Antonella E. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Fisicoquímica; Argentina. Fil: Montemerlo, Antonella E. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Físico-Química de Córdoba; Argentina. Fil: Rivas, Gustavo A. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Fisicoquímica; Argentina. Fil: Rivas, Gustavo A. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Físico-Química de Córdoba; Argentina. Fil: Rubianes, María D. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Fisicoquímica; Argentina. Fil: Rubianes, María D. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Físico-Química de Córdoba; Argentina. Fil: Baiardi, Gustavo. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas, Físicas y Naturales. Laboratorio de Neurofarmacología; Argentina. Fil: Baiardi, Gustavo. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones Biológicas y Tecnológicas; Argentina. Fil: Bregonzio, Claudia. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Fisicoquímica; Argentina. Fil: Bregonzio, Claudia. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Farmacología Experimental de Córdoba; Argentina. 2024-07-29T16:20:00Z 2024-07-29T16:20:00Z 2024-05-21 article Basmadjian, O. M., Occhieppo, V. B., Montemerlo, A. E., Rivas, G. A., Rubianes, M. D., Baiardi, G., &Bregonzio, C. (2024). Angiotensin II involvement in the development and persistence of amphetamine‐induced sensitization: Striatal dopamine reuptake implications. European Journal of Neuroscience, 59(10), 2450-2464. http://hdl.handle.net/11086/552953 1460-9568 https://rdu.unc.edu.ar/handle/11086/18306 https://onlinelibrary.wiley.com/doi/abs/10.1111/ejn.16312 https://pubmed.ncbi.nlm.nih.gov/38480476/ https://doi.org/10.1111/ejn.16312 eng Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ Federation of European Neuroscience Societies